title: Unresponsiveness to recombinant human erythropoietin in haemodialysis patients: possible implications of angiotensin-converting enzyme inhibitors.
authors.forename: S
authors.initials: S
authors.lastname: Ertürk
authors.forename: K
authors.initials: K
authors.lastname: Ateş
authors.forename: N
authors.initials: N
authors.lastname: Duman
authors.forename: O
authors.initials: O
authors.lastname: Karatan
authors.forename: B
authors.initials: B
authors.lastname: Erbay
authors.forename: E
authors.initials: E
authors.lastname: Ertuğ
mesh_terms: D000293:Adolescent; D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D004351:Drug Resistance; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D011994:Recombinant Proteins; D004921:Erythropoietin